Teva, Drugmakers in Talks With U.S. to End Generics Probes November 26, 2019 Robert I. Field, PhD, JD, a professor in the Kline School of Law and Dornsife School of Public Health, was quoted in a Nov. 25 Bloomberg article about the talks Teva Pharmaceutical Industries Itd. and other generic drugmakers have had with the U.S. Justice Department in the past six months about resolving a long-running criminal antitrust probe of alleged price-fixing by the companies. View story
icon above to turn off Compatibility Mode, which is only for viewing older websites.